"Excel Clinical Research is a dedicated research site that conducts Phase I-IV research studies in Las Vegas, Nevada. We are committed to providing our Sponsors and CROs with the highest quality of data while meeting or exceeding our enrollment goals!"

During the past decade, Excel Clinical Research conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 18 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 18 clinical trials were completed. i.e. 51.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Excel Clinical Research" #1 sponsor was "Pfizer" with 8 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Allergan" with 4 trials sponsored, "Urovant Sciences GmbH" with 4 trials sponsored and "Astellas Pharma Global Development, Inc." with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Excel Clinical Research" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Excel Clinical Research" are "COVID-19" (5 trials), "Overactive Bladder" (4 trials), "Arthritis, Psoriatic" (3 trials), "Diabetes Mellitus" (3 trials) and "Gastroparesis" (3 trials). Many other conditions were trialed in "Excel Clinical Research" in a lesser frequency.

Most popular intervention types in "Excel Clinical Research" are "Drug" (36 trials), "Biological" (7 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Guselkumab" (3 trials), "PF-07321332" (3 trials), "Relamorelin" (3 trials) and "Ritonavir" (3 trials). Other intervention names were less common.

The vast majority of trials in "Excel Clinical Research" are 38 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Excel Clinical Research". undefined are not yet recruiting, 14 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Excel Clinical Research, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Excel Clinical Research, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".